SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Autohome (ATHM) Tops Q2 EPS by 42c
• BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy